Skip to content

Drug interactions

Lomitapide + Saxagliptin-metformin

Severity: Minor

Lomitapide and Saxagliptin-metformin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide inhibits P-glycoprotein and may raise exposure to saxagliptin, which is a P-gp substrate. The clinical significance is probably modest, since saxagliptin has a wide margin of safety.

What this interaction means in plain words

Lomitapide and Saxagliptin-metformin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lomitapide belongs to Cardiovascular; Saxagliptin-metformin belongs to Endocrine.

Evidence level: Low

Why it happens

Lomitapide inhibits P-glycoprotein efflux, potentially increasing saxagliptin absorption and reducing its elimination.

What to do

Monitor for saxagliptin adverse effects such as hypersensitivity or pancreatitis symptoms, and reduce the saxagliptin dose if these emerge. Lomitapide labeling advises dose reduction of P-gp substrates.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomitapide and Saxagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomitapide with Saxagliptin-metformin?

MediHelp rates the interaction as minor. Lomitapide and Saxagliptin-metformin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lomitapide inhibits P-glycoprotein and may raise exposure to saxagliptin, which is a P-gp substrate. The clinical significance is probably modest, since saxagliptin has a wide margin of safety.

How serious is the interaction between Lomitapide and Saxagliptin-metformin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for saxagliptin adverse effects such as hypersensitivity or pancreatitis symptoms, and reduce the saxagliptin dose if these emerge. Lomitapide labeling advises dose reduction of P-gp substrates.

What other medicines interact with Saxagliptin-metformin?

MediHelp also lists interactions of Saxagliptin-metformin with, for example, Atazanavir, Clozapine, Contrast media. The full list is on the Saxagliptin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in